| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01530984 Details | 2015-10-05 Interventional | 2 | 0 | Ipilimumab Sargramostim Prostatic Neopl… Prostate Cancer | Unable to execute contract - | |||
| NCT02316249 Details | 2015-10-02 Interventional | 2 | 0 | Estradiol Atrophy Pelvic Organ Pr… Ulcer Vaginitis Atrophy of Vagi… Vaginal Ulcerat… | the study was not feasible - | |||
| NCT01911377 Details | 2015-10-02 Interventional | 2 | 12 | Botulinum Toxin… Botulinum Toxin… abobotulinumtox… Hyperalgesia Neuralgia Allodynia Neuropathic Pai… | 12 SCI volunteers completed the study. As the data analysis was negative, the decision was made
not to proceed with MS recruitment. - | |||
| NCT01426113 Details | 2015-10-02 Interventional | 3 | 6 | Bimatoprost Ophthalmic Solu… Pharmaceutical … Timolol Glaucoma | Study terminated due to corporate decision. - | |||
| NCT01004419 Details | 2015-10-02 Interventional | 1 | 0 | Fulvestrant Carcinoma, Non-… Lung Neoplasms Carcinoma, Non … | Support for investigational products has been withdrawn. - | |||
| NCT00518687 Details | 2015-10-02 Interventional | 2/3 | 8031 | Vaccines Bacteremia Mediastinitis Staphylococcus … | - - | |||
| NCT01930877 Details | 2015-10-01 Interventional | 2 | 0 | Lidocaine Pain | Withdrawn by PI - | |||
| NCT00923117 NCT00713388 Details | 2015-09-30 Interventional | 2 | 87 | Sunitinib Glioblastoma Glioma Anaplastic Glio… Glioblastoma Mu… Malignant Gliom… | The study was terminated based on results of an interim analysis for futility. The study was terminated based on results of an interim analysis for futility. | |||
| NCT00411281 Details | 2015-09-30 Interventional | 3 | 0 | Cytarabine Down Syndrome Leukemoid React… Myeloproliferat… Leukemia | Per Group Chair: This study will not move forward. - | |||
| NCT00384293 Details | 2015-09-30 Interventional | 3 | 937 | Niacin Hypercholestero… Hyperlipoprotei… Hypercholestero… | - After a detailed review of pooled carotid IMT data from contemporary studies, the Steering Committee recommended that Merck prematurely stop the study; as designed, the study was significantly underpowered. Efficacy analyses were not performed. | |||
| NCT01625741 Details | 2015-09-29 Interventional | 2 | 6 | Rituximab Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | Stopped by Principal Investigator decision - | |||
| NCT01193881 Details | 2015-09-29 Interventional | 1 | 16 | 2,2-dimethyl-N-… Erlotinib Hydro… Gamma Secretase… Carcinoma, Non-… Lung Neoplasms Recurrent Non-S… Stage IV Non-Sm… | - - | |||
| NCT00873886 Details | 2015-09-29 Interventional | 1 | 0 | Oseltamivir Influenza Pregnancy | We will focus on other Tamiflu research studies. No subjects were enrolled. - | |||
| NCT01834274 2013-000542-19 Details | 2015-09-28 Interventional | 3 | 96 | Metformin Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… | Due to potential concerns about liver safety (See Detailed Description) - | |||
| NCT01598584 Details | 2015-09-28 Interventional | 2/3 | 0 | Gemcitabine Mirtazapine Pancreatic Neop… Pancreatic Canc… | Gemcitabine is not the first choice for most pancreatic cancer patients nowdays - | |||
| NCT00298272 Details | 2015-09-28 Interventional | 2 | [1 Refs] | 54 | Adalimumab Etanercept Methotrexate Methylprednisol… Rituximab Arthritis Arthritis, Rheu… Rheumatoid Arth… | Sponsor decided to end long term extension phase for business reasons unrelated to safety. Sponsor made a business decision to terminate study on 28 July 2011, after completion of the primary endpoint and during the long-term extension phase. One participant was still in extended safety follow-up and was referred for appropriate care. | ||
| NCT02150161 Details | 2015-09-25 Interventional | 3 | 53 | Fentanyl Ketamine Lidocaine Opioid Free Ana… Postoperative A… | DSMB estimated futility of the trial and safety risk - | |||
| NCT01734824 Details | 2015-09-23 Interventional | 4 | - | Denosumab Parathyroid Hor… Teriparatide Bone Diseases Edema Bone Marrow Oed… High Turnover B… Quality of Life | no patients randomized - | |||
| NCT00377780 Details | 2015-09-23 Interventional | 2 | 60 | Docetaxel Doxorubicin Liposomal doxor… Trastuzumab Breast Neoplasm… Neoplasm Metast… Breast Cancer | wothdrawal of sponsor - | |||
| NCT00056979 Details | 2015-09-23 Interventional | 1/2 | 2 | Alemtuzumab Fludarabine Metabolic Disea… Inherited Metab… | - - |